153 related articles for article (PubMed ID: 25280230)
1. Watchful waiting: role of disease progression on uncertainty and depressive symptoms in patients with chronic hepatitis C.
Colagreco JP; Bailey DE; Fitzpatrick JJ; Musil CM; Afdhal NH; Lai M
J Viral Hepat; 2014 Oct; 21(10):727-33. PubMed ID: 25280230
[TBL] [Abstract][Full Text] [Related]
2. Uncertainty, symptoms, and quality of life in persons with chronic hepatitis C.
Bailey DE; Landerman L; Barroso J; Bixby P; Mishel MH; Muir AJ; Strickland L; Clipp E
Psychosomatics; 2009; 50(2):138-46. PubMed ID: 19377022
[TBL] [Abstract][Full Text] [Related]
3. Watchful waiting for subthreshold depression and anxiety in visually impaired older adults.
van der Aa HP; Krijnen-de Bruin E; van Rens GH; Twisk JW; van Nispen RM
Qual Life Res; 2015 Dec; 24(12):2885-93. PubMed ID: 26085328
[TBL] [Abstract][Full Text] [Related]
4. Interferon alpha (pegylated and non-pegylated) and ribavirin for the treatment of mild chronic hepatitis C: a systematic review and economic evaluation.
Shepherd J; Jones J; Hartwell D; Davidson P; Price A; Waugh N
Health Technol Assess; 2007 Mar; 11(11):1-205, iii. PubMed ID: 17346498
[TBL] [Abstract][Full Text] [Related]
5. Patients with chronic hepatitis C undergoing watchful waiting: Exploring trajectories of illness uncertainty and fatigue.
Bailey DE; Barroso J; Muir AJ; Sloane R; Richmond J; McHutchison J; Patel K; Landerman L; Mishel MH
Res Nurs Health; 2010 Oct; 33(5):465-73. PubMed ID: 20730869
[TBL] [Abstract][Full Text] [Related]
6. The experience of adults who choose watchful waiting or active surveillance as an approach to medical treatment: a qualitative systematic review.
Rittenmeyer L; Huffman D; Alagna M; Moore E
JBI Database System Rev Implement Rep; 2016 Feb; 14(2):174-255. PubMed ID: 27536798
[TBL] [Abstract][Full Text] [Related]
7. Prospective evaluation of liver fibrosis in chronic viral hepatitis C infection using the Sabadell NIHCED (Non-Invasive Hepatitis-C-Related Cirrhosis Early Detection) index.
Bejarano G; Vergara M; Dalmau B; Puig J; Bella MR; Suárez D; Calvet X
Rev Esp Enferm Dig; 2009 May; 101(5):325-35. PubMed ID: 19527078
[TBL] [Abstract][Full Text] [Related]
8. Progression of hepatic fibrosis in patients with hepatitis C: a prospective repeat liver biopsy study.
Ryder SD; Irving WL; Jones DA; Neal KR; Underwood JC;
Gut; 2004 Mar; 53(3):451-5. PubMed ID: 14960533
[TBL] [Abstract][Full Text] [Related]
9. Liver fibrosis progression at autopsy in injecting drug users infected by hepatitis C: a longitudinal long-term cohort study.
Kielland KB; Delaveris GJ; Rogde S; Eide TJ; Amundsen EJ; Dalgard O
J Hepatol; 2014 Feb; 60(2):260-6. PubMed ID: 24096048
[TBL] [Abstract][Full Text] [Related]
10. Mild alcohol consumption is not associated with increased fibrosis in patients with chronic hepatitis C.
Cheung O; Sterling RK; Salvatori J; Williams K; Hubbard S; Luketic VA; Stravitz TR; Sanyal AJ; Contos MJ; Mills S; Shiffman ML
J Clin Gastroenterol; 2011 Jan; 45(1):76-82. PubMed ID: 20818236
[TBL] [Abstract][Full Text] [Related]
11. Defer or treat? Reasons for treatment decisions in patients with chronic hepatitis C genotype 1 in the early era of directly acting antiviral agents.
Kittner JM; Weiss NM; Wiltink J; Schattenberg JM; Grambihler A; Thieringer F; Weinmann A; Zimmermann T; Koch S; Schuchmann M; Galle PR
Dig Liver Dis; 2014 Jan; 46(1):67-71. PubMed ID: 24125691
[TBL] [Abstract][Full Text] [Related]
12. Comparison and correlation of fibrosis stage assessment by collagen proportionate area (CPA) and the ELF panel in patients with chronic liver disease.
Stasi C; Tsochatzis EA; Hall A; Rosenberg W; Milani S; Dhillon AP; Pinzani M
Dig Liver Dis; 2019 Jul; 51(7):1001-1007. PubMed ID: 30606698
[TBL] [Abstract][Full Text] [Related]
13. Noninvasive serum fibrosis markers for screening and staging chronic hepatitis C virus patients in a large US cohort.
Holmberg SD; Lu M; Rupp LB; Lamerato LE; Moorman AC; Vijayadeva V; Boscarino JA; Henkle EM; Gordon SC;
Clin Infect Dis; 2013 Jul; 57(2):240-6. PubMed ID: 23592832
[TBL] [Abstract][Full Text] [Related]
14. A seven-gene signature (cirrhosis risk score) predicts liver fibrosis progression in patients with initially mild chronic hepatitis C.
Marcolongo M; Young B; Dal Pero F; Fattovich G; Peraro L; Guido M; Sebastiani G; Palù G; Alberti A
Hepatology; 2009 Oct; 50(4):1038-44. PubMed ID: 19676127
[TBL] [Abstract][Full Text] [Related]
15. Can serum hyaluronic acid replace simple non-invasive indexes to predict liver fibrosis in HIV/Hepatitis C coinfected patients?
Resino S; Bellón JM; Asensio C; Micheloud D; Miralles P; Vargas A; Catalán P; López JC; Alvarez E; Cosin J; Lorente R; Muñoz-Fernández MA; Berenguer J
BMC Infect Dis; 2010 Aug; 10():244. PubMed ID: 20723207
[TBL] [Abstract][Full Text] [Related]
16. Long term changes in liver histology following treatment of chronic hepatitis C virus.
Shiffman ML; Sterling RK; Contos M; Hubbard S; Long A; Luketic VA; Stravitz RT; Fuchs M; Sanyal AJ
Ann Hepatol; 2014; 13(4):340-9. PubMed ID: 24927604
[TBL] [Abstract][Full Text] [Related]
17. Role of a cirrhosis risk score for the early prediction of fibrosis progression in hepatitis C patients with minimal liver disease.
Trépo E; Potthoff A; Pradat P; Bakshi R; Young B; Lagier R; Moreno C; Verset L; Cross R; Degré D; Lemmers A; Gustot T; Berthillon P; Rosenberg W; Trépo C; Sninsky J; Adler M; Wedemeyer H
J Hepatol; 2011 Jul; 55(1):38-44. PubMed ID: 21145859
[TBL] [Abstract][Full Text] [Related]
18. Comparing the efficiency of Fib-4, Egy-score, APRI, and GUCI in liver fibrosis staging in Egyptians with chronic hepatitis C.
Cordie A; Salama A; El-Sharkawy M; El-Nahaas SM; Khairy M; Elsharkawy A; Hassany M; Esmat G
J Med Virol; 2018 Jun; 90(6):1106-1111. PubMed ID: 29476628
[TBL] [Abstract][Full Text] [Related]
19. Fatigue and depressive symptoms associated with chronic viral hepatitis patients. health-related quality of life (HRQOL).
Karaivazoglou K; Iconomou G; Triantos C; Hyphantis T; Thomopoulos K; Lagadinou M; Gogos C; Labropoulou-Karatza C; Assimakopoulos K
Ann Hepatol; 2010; 9(4):419-27. PubMed ID: 21057161
[TBL] [Abstract][Full Text] [Related]
20. Relationship between genotypes of hepatitis C virus and histopathological manifestations in chronic hepatitis C patients.
Adinolfi LE; Utili R; Andreana A; Tripodi MF; Rosario P; Mormone G; Ragone E; Pasquale G; Ruggiero G
Eur J Gastroenterol Hepatol; 2000 Mar; 12(3):299-304. PubMed ID: 10750650
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
